Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boggild

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of the Neurological Sciences|March 6, 2016
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disabilityS Huda, A Cavey, A Izat, et al.
Clinical Rehabilitation|September 29, 2006
A randomized controlled trial of a health promotion education programme for people with multiple sclerosisM Ennis, J Thain, M Boggild, et al.
Hormone Research|January 1, 1997
Tumour suppressor genes in the pathogenesis of human pituitary tumoursR N Clayton, M Boggild, A S Bates, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2010
A window of opportunity for no treatment in early multiple sclerosis?C P Gilmore, D A Cottrell, N J Scolding, et al.
Journal of Neuroimmunology|December 2, 1999
Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosisC Pickard, C Mann, P Sinnott, et al.
European Journal of Neurology|June 10, 2010
EFNS guidelines on diagnosis and management of neuromyelitis opticaJ Sellner, M Boggild, M Clanet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiationJ A Woolmore, M Stone, E M Pye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosisG Mamutse, J Woolmore, E Pye, et al.
Neurology|July 29, 2011
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohortM Cossburn, A A Pace, J Jones, et al.
Journal of Neurology|July 6, 2020
Treatment of MOG antibody associated disorders: results of an international surveyD H Whittam, V Karthikeayan, E Gibbons, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of the Neurological Sciences|March 6, 2016
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disabilityS Huda, A Cavey, A Izat, et al.
Clinical Rehabilitation|September 29, 2006
A randomized controlled trial of a health promotion education programme for people with multiple sclerosisM Ennis, J Thain, M Boggild, et al.
Hormone Research|January 1, 1997
Tumour suppressor genes in the pathogenesis of human pituitary tumoursR N Clayton, M Boggild, A S Bates, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2010
A window of opportunity for no treatment in early multiple sclerosis?C P Gilmore, D A Cottrell, N J Scolding, et al.
Journal of Neuroimmunology|December 2, 1999
Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosisC Pickard, C Mann, P Sinnott, et al.
European Journal of Neurology|June 10, 2010
EFNS guidelines on diagnosis and management of neuromyelitis opticaJ Sellner, M Boggild, M Clanet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiationJ A Woolmore, M Stone, E M Pye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosisG Mamutse, J Woolmore, E Pye, et al.
Neurology|July 29, 2011
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohortM Cossburn, A A Pace, J Jones, et al.
Journal of Neurology|July 6, 2020
Treatment of MOG antibody associated disorders: results of an international surveyD H Whittam, V Karthikeayan, E Gibbons, et al.
Pageof 2